Welcome to our dedicated page for MedWellAI SEC filings (Ticker: MWAI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on MedWellAI's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into MedWellAI's regulatory disclosures and financial reporting.
MedWellAI, Inc. (MWAI) filed its quarterly report and reported a shift toward commission-based health and wellness distribution while posting a smaller loss. Revenue was
Liquidity remains tight. Cash was
MedWellAI, Inc. reports a difficult year with material impairments, debt defaults and a large accumulated deficit that raise substantial doubt about its ability to continue as a going concern. The company acquired 51% of Healthy Lifestyle and recorded a $670,329 goodwill impairment after deciding to abandon that business; earn-out targets tied to Healthy Lifestyle were not met so no post-closing payments are due. The company reported an accumulated deficit of $88,673,880 and disclosed operations that produced cash shortfalls. A note payable went into default and the lender reduced default interest to 10% effective April 1, 2024; interest expense of $50,694 and $81,389 was recorded in fiscal 2025 and 2024. Management also issued 50,000 Series B preferred shares to a related party, valued on an as-converted basis at $8,300,000, convertible at 100:1. The filing discloses discontinued mining operations and other one-time adjustments but lacks full, contiguous financial tables in this extract.
FAQ
What is the current stock price of MedWellAI (MWAI)?
What is the market cap of MedWellAI (MWAI)?
